Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMI PROTECT (Work Package 2): Calcium Channel Blocker Treatments and Cancer Risk

NCT01587742 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01587742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01587742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMI PROTECT (Work Package 2): Calcium Channel Blocker Treatments and Cancer Risk
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
November 30, 2011
Completion date
August 31, 2014
Enrollment
1 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension